Skip To Main Content
Qiushi Yin on Muck Rack

Qiushi Yin

As seen in: Nature, Wiley Online Library, Frontiers in Public Health, MDPI, ACS Publications, Royal Society of Chemistry
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Qiushi

Contact Qiushi, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Bidirectional longitudinal associations between low anterior resection syndrome and stigma in patients with postoperative LARS: a cross-lagged panel study

|
By Xiangdong Hu, Qiushi Yin, Mei Cao, Hui Yang, Changcui Liang
| Frontiers in Public Health Verified
Abstract Objective: To investigate the bidirectional longitudinal associations between low anterior resection syndrome (LARS) and stigma among patients with postoperative LARS following sphincter-preserving surgery for rectal cancer. Methods: A total of 201 patients with LARS after sphincter-preserving surgery for rectal cancer were recruited using convenience sampling between March 2024 and June 2025. Follow-up was completed in December 2025.
Open in Who Shared Issue with article?

HBx Drives Liver Cancer Stem Cell Generation Through Stimulating Glucose Metabolic Reprogramming

|
By Jinchen Liu, Xueqin Wu, Qiushi Yin, Luying Zhang
| Wiley Online Library Verified
AFP alpha-fetoprotein ATP adenosine triphosphate CSCs cancer stem cells EpCAM epithelial cellular adhesion molecule GAPDH glyceraldehyde 3-phosphate dehydrogenase GLUTs glucose transporters HBx hepatitis B virus x protein HCC hepatocellular carcinoma hESCs human embryonic stem cells HK2 Hexokinase2 LCSCs liver cancer stem cells LDH lactate dehydrogenase LDHA lactate dehydrogenase A mTOR mammalian target of rapamycin PI3K/Akt phosphatidylinositol 3-kinase/protein kinase B PKM2 pyruvate kinase...
Open in Who Shared Issue with article?

EZH2‐Mediated PHF10 Suppression Amplifies HMGB1/NF‐κB Axis That Confers Chemotherapy Resistance in Cholangiocarcinoma

|
By Qiushi Yin, Daning Lin, Weiqian Zeng, Shijing Gu
| Wiley Online Library Verified
1 Introduction Cholangiocarcinoma (CHOL), also known as bile duct cancer, is a relatively rare but aggressive form of cancer that originates in the cells of the bile ducts [1]. In most cases, surgical resection remains the only curative option [2]. However, the majority of patients present at an advanced stage when not amenable to surgical resection [3]. Gemcitabine and cisplatin are most widely used chemotherapeutic agents for CHOL.
Open in Who Shared Issue with article?
See all 7 articles